<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr J</journal-id><journal-id journal-id-type="iso-abbrev">Nutr J</journal-id><journal-title-group><journal-title>Nutrition Journal</journal-title></journal-title-group><issn pub-type="epub">1475-2891</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28499426</article-id><article-id pub-id-type="pmc">5427583</article-id><article-id pub-id-type="publisher-id">253</article-id><article-id pub-id-type="doi">10.1186/s12937-017-0253-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum to: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ohara</surname><given-names>Tatsuya</given-names></name><address><email>Ohara_Tatsuya@house-wf.co.jp</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Muroyama</surname><given-names>Koutarou</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Yamamoto</surname><given-names>Yoshihiro</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Murosaki</surname><given-names>Shinji</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Research &#x00026; Development Institute, House Wellness Foods Corporation, 3-20 Imoji, Itami, Hyogo 664-0011 Japan </aff></contrib-group><pub-date pub-type="epub"><day>12</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="pmc-release"><day>12</day><month>5</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>16</volume><elocation-id>28</elocation-id><history><date date-type="received"><day>10</day><month>5</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2017</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><related-article related-article-type="corrected-article" id="d29e67" ext-link-type="doi" xlink:href="10.1186/s12937-016-0123-7"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2017</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Erratum</title><p>After publication of this article [<xref ref-type="bibr" rid="CR1">1</xref>] it was noticed there were errors in the paper regarding the dose and grade of glucosyl hesperidin due to miscommunications.</p><p>The composition of glucosyl hesperidin is reported as &#x0201c;500&#x000a0;mg&#x0201d; but this should instead be listed as &#x0201c;470&#x000a0;mg&#x0201d; throughout the article. Additionally, the G-hesperidin should be reported as containing 74% monoglucosyl hesperidin and residual non-glycosylated hesperidin.</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1186/s12937-016-0123-7.</p></fn></fn-group><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohara</surname><given-names>T</given-names></name><name><surname>Muroyama</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Murosaki</surname><given-names>S</given-names></name></person-group><article-title>Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial</article-title><source>Nutr J</source><year>2016</year><volume>15</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s12937-016-0123-7</pub-id><pub-id pub-id-type="pmid">26786000</pub-id></element-citation></ref></ref-list></back></article>